Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Scambia

Showing results (201-210 of 551) with videos related to

Pageof 56
Sort By:
International Journal of Cancer|December 10, 1999
Activity of cisplatin and ICI 182,780 on estrogen receptor negative ovarian cancer cells: cell cycle and cell replication rate perturbation, chromatin texture alteration and apoptosis inductionA Ercoli, A Battaglia, G Raspaglio, et al.
British Journal of Cancer|August 1, 1995
Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapyG Scambia, P Benedetti-Panici, G Ferrandina, et al.
International Journal of Cancer|April 22, 1996
Cathepsin D concentration in primary laryngeal cancer: correlation with clinico-pathological parameters, EGFR status and prognosisM Maurizi, G Almadori, G Cadoni, et al.
Journal of Reproductive Immunology|June 27, 2018
HLA-DR is aberrantly expressed at feto-maternal interface in pre-eclampsiaC Tersigni, C W Redman, R Dragovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinomaG Almadori, G Cadoni, P Cattani, et al.
Journal of Clinical Pathology|December 1, 1990
Type II oestrogen binding sites in human colorectal carcinomaM Piantelli, R Ricci, L M Larocca, et al.
Gynecologic Oncology|April 16, 2013
Robotic single-site hysterectomy (RSS-H) vs. laparoendoscopic single-site hysterectomy (LESS-H) in early endometrial cancer: a double-institution case-control studyA Fagotti, G Corrado, F Fanfani, et al.
Annals of Surgical Oncology|February 15, 2021
Rectosigmoid Mesorectal-Sparing Resection in Advanced Ovarian Cancer SurgeryA Rosati, V Vargiu, F Santullo, et al.
Computational and Structural Biotechnology Journal|December 6, 2024
ALOA, a pipeline for preliminary analysis of spatial profiling imaging dataC Parrillo, F Persiani, G Mantini, et al.
Cancer|December 1, 1996
Modified type IV-V radical hysterectomy with systematic pelvic and aortic lymphadenectomy in the treatment of patients with stage III cervical carcinoma. Feasibility, technique, and clinical resultsP Benedetti-Panici, F Maneschi, G Cutillo, et al.
Pageof 56

Showing results (201-210 of 551) with videos related to

Sort By:
Pageof 56
International Journal of Cancer|December 10, 1999
Activity of cisplatin and ICI 182,780 on estrogen receptor negative ovarian cancer cells: cell cycle and cell replication rate perturbation, chromatin texture alteration and apoptosis inductionA Ercoli, A Battaglia, G Raspaglio, et al.
British Journal of Cancer|August 1, 1995
Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapyG Scambia, P Benedetti-Panici, G Ferrandina, et al.
International Journal of Cancer|April 22, 1996
Cathepsin D concentration in primary laryngeal cancer: correlation with clinico-pathological parameters, EGFR status and prognosisM Maurizi, G Almadori, G Cadoni, et al.
Journal of Reproductive Immunology|June 27, 2018
HLA-DR is aberrantly expressed at feto-maternal interface in pre-eclampsiaC Tersigni, C W Redman, R Dragovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinomaG Almadori, G Cadoni, P Cattani, et al.
Journal of Clinical Pathology|December 1, 1990
Type II oestrogen binding sites in human colorectal carcinomaM Piantelli, R Ricci, L M Larocca, et al.
Gynecologic Oncology|April 16, 2013
Robotic single-site hysterectomy (RSS-H) vs. laparoendoscopic single-site hysterectomy (LESS-H) in early endometrial cancer: a double-institution case-control studyA Fagotti, G Corrado, F Fanfani, et al.
Annals of Surgical Oncology|February 15, 2021
Rectosigmoid Mesorectal-Sparing Resection in Advanced Ovarian Cancer SurgeryA Rosati, V Vargiu, F Santullo, et al.
Computational and Structural Biotechnology Journal|December 6, 2024
ALOA, a pipeline for preliminary analysis of spatial profiling imaging dataC Parrillo, F Persiani, G Mantini, et al.
Cancer|December 1, 1996
Modified type IV-V radical hysterectomy with systematic pelvic and aortic lymphadenectomy in the treatment of patients with stage III cervical carcinoma. Feasibility, technique, and clinical resultsP Benedetti-Panici, F Maneschi, G Cutillo, et al.
Pageof 56